Navigation Links
Amylin Pharmaceuticals to Present at BIOCOM Investor Conference
Date:10/23/2008

SAN DIEGO, Oct. 23 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) will be presenting at the BIOCOM Investor Conference in San Diego on Tuesday, October 28, 2008 at 10:30 a.m. PT. Mark G. Foletta, Amylin's Senior Vice President of Finance and Chief Financial Officer, will be providing a corporate overview.

The live presentation will be Web cast, and a recording will be made available following the event. The Web cast and recording will be accessible through Amylin's corporate Web site, located at http://www.amylin.com. To access the live Web cast, please log on to Amylin's site approximately fifteen minutes prior to the presentation to register and download any necessary audio software.

About Amylin Pharmaceuticals

Amylin Pharmaceuticals is a biopharmaceutical company committed to improving lives through the discovery, development and commercialization of innovative medicines. Amylin has developed and gained approval for two first-in-class medicines for diabetes, SYMLIN(R) (pramlintide acetate) injection and BYETTA(R) (exenatide) injection. Amylin's research and development activities leverage the company's expertise in metabolism to develop potential therapies to treat diabetes and obesity. Amylin is headquartered in San Diego, California with over 2,000 employees nationwide. Further information on Amylin Pharmaceuticals is available at http://www.amylin.com.


'/>"/>
SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Lilly and Amylin Enter Into Supply Agreement for Exenatide Once Weekly
2. Amylin Pharmaceuticals Reports Third Quarter Financial Results
3. Amylin Pharmaceuticals to Webcast Third Quarter Results
4. Amylin Pharmaceuticals to Present at Thomas Weisel Healthcare, BioCentury NewsMakers, and Morgan Stanley Global Healthcare Conferences
5. Amylin Pharmaceuticals and Eli Lilly Provide Context for FDA Alert for BYETTA
6. Amylin and Lilly Set Date and Time for Conference Call
7. Amylin Pharmaceuticals to Webcast Second Quarter Results
8. Amylin Pharmaceuticals to Present at Goldman Sachs Global Healthcare Conference
9. Amylin Pharmaceuticals to Present Promising Data From Diabetes and Obesity Programs at ADA 2008
10. Amylin Pharmaceuticals to Present at Annual Meeting of Stockholders
11. Amylin Pharmaceuticals to Present at FBR Capital Markets Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... According to a new market research report "Aptamers Market ... by Technology (SELEX, Other Technologies), by End Users (Academic Research ... 2020", published by MarketsandMarkets, the global Aptamers Market is expected ... 2015, at a CAGR of 17.89%. Browse ... igures spread through 125 P ages ...
(Date:6/29/2015)... --  For the seventh year running, Across Health conducted a ... maturity called the Multichannel Maturometer . The research ... fast enough. While it,s true that technology is indeed ... customers are increasingly "digital natives", pharma still lags behind ... Logo ...
(Date:6/26/2015)... Kan. , June 26, 2015 /PRNewswire/ ... PETX ), a pet therapeutics company focused ... innovative biopharmaceutical products for companion animals, today ... effectiveness study of capromorelin (AT-002), the company,s ... Capromorelin is a small molecule that mimics ...
(Date:6/26/2015)... June 26, 2015  A San Francisco company, Pembient, ... with synthetic rhino horn: beer in China ... . In response to the emerging industry, two ... and sale of synthetic rhino horn.  ... Save the Rhino International (SRI) released a ...
Breaking Biology Technology:Aptamers Market Worth $244.93 Million by 2020 2Aptamers Market Worth $244.93 Million by 2020 3Aptamers Market Worth $244.93 Million by 2020 4Results from Digital Maturity Study Show Pharma Lagging 2Results from Digital Maturity Study Show Pharma Lagging 3Results from Digital Maturity Study Show Pharma Lagging 4Aratana Therapeutics Announces Positive Pivotal Results for AT-002 2Aratana Therapeutics Announces Positive Pivotal Results for AT-002 3Aratana Therapeutics Announces Positive Pivotal Results for AT-002 4Aratana Therapeutics Announces Positive Pivotal Results for AT-002 5Rhino Experts Oppose Synthetic Rhino Horn as Solution to Poaching Crisis 2
... research led by the U.S. Department of Energy,s Argonne ... understanding of new mechanisms, which makes it possible to ... may enable computers to more accurately write and store ... of Hamburg used a special scanning tunneling microscope equipped ...
... has been used for years to cool trapped atomsand ... thermal motion. Now, applying a different form of radiation ... of Standards and Technology (NIST) have used radio waves ... containing more than a quadrillion atoms, a cooling technique ...
... 14 Viragen, Inc. (OTC,Bulletin Board: VRAI) ... Bulletin Board: VRGE), today jointly announced,that Viragen ... Sweden, filed an application seeking protection under ... a,multi-subtype, human alpha interferon. The bankruptcy ...
Cached Biology Technology:Researchers improve ability to write and store information on electronic devices 2'Radio wave cooling' offers new twist on laser cooling 2Viragen International's Subsidiary, ViraNative AB, Files to Seek Bankruptcy Protection in Sweden 2
(Date:6/25/2015)... , June 25, 2015 ... Market by Type (Swipe & Area), Technology, Material (Optical ... Healthcare, Commercial Security & Others) & Geography - ... marketsandmarkets, the said market is expected to reach ... 17.1%. Browse 76 market Tables ...
(Date:6/24/2015)... 24, 2015  Synaptics Inc. (NASDAQ: SYNA ... today announced that Sharp has selected its industry-leading ... for its latest flagship smartphone device, the AQUOS ... million shipments of its fingerprint ID sensor technology, ... scalability and leadership in the biometrics market through ...
(Date:6/23/2015)... 23, 2015   Valencell, a leader ... of a recent study that illustrates its PerformTek ... during activity. In a study conducted at Valencell,s ... with the Apple Watch against a chest strap ... during activity. The study demonstrated that Valencell,s biometric ...
Breaking Biology News(10 mins):Fingerprint Sensors Market Worth $14,500.07 Million by 2020 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 3Fingerprint Sensors Market Worth $14,500.07 Million by 2020 4Synaptics Brings Natural ID Technology to Sharp's Newest Flagship Smartphone 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 3
... August 13, 2013, S. Korea. A collaboration between the ... Pasteur Korea (IP-K) to spur the fight against neglected ... entered into a Master Research Agreement for collaboration in ... treatments for patients suffering from neglected diseases. Under the ...
... been recently published in Geophysical Research Letters ( ... JGR-B ) and Journal of Geophysical Research-Atmospheres ( ... in Japan caused large waves in Norwegian fjords, 2. Disposal ... The Arctic is especially sensitive to black carbon emissions from ...
... switch that can either increase or decrease memory-building activity ... Its dual role means the protein is key to ... brain,s circuitry, the researchers say. A description of their ... Journal of Neuroscience ., "What,s interesting about this ...
Cached Biology News:Institut Pasteur Korea -- DNDi come together for the fight against neglected diseases 2AGU journal highlights -- Aug. 13, 2013 2AGU journal highlights -- Aug. 13, 2013 3AGU journal highlights -- Aug. 13, 2013 4AGU journal highlights -- Aug. 13, 2013 5AGU journal highlights -- Aug. 13, 2013 6AGU journal highlights -- Aug. 13, 2013 7AGU journal highlights -- Aug. 13, 2013 8Newly discovered 'switch' plays dual role in memory formation 2